The many worlds of reducing interleukin‐1

2005/06/28 by Charles A. Dinarello · 14 citations
Biochemistry, Genetics and Molecular Biology · Immunology and Microbiology · #Inflammasome and immune disorders #Immune Cell Function and Interaction #Immune Response and Inflammation

paper · doi:10.1002/art.21107

Cited by

• Pathogenic and therapeutic roles of cytokines in Kawasaki diseases
• Microarray-based identification of novel biomarkers in IL-1-mediated diseases. [europepmc]
• A broad analysis of IL1 polymorphism and rheumatoid arthritis. [europepmc]
• Anakinra for rheumatoid arthritis. [europepmc]
• Canakinumab (ACZ885, a fully human IgG1 anti-IL-1β mAb) induces sustained remission in pediatric patients with cryopyrin-associated periodic syndrome (CAPS). [europepmc]
• Management of hypersensivity pneumonitis. [europepmc]
• Anti-cytokine therapies in T1D: Concepts and strategies. [europepmc]
• Comparative evaluation of the effects of treatment with tocilizumab and TNF-α inhibitors on serum hepcidin, anemia response and disease activity in rheumatoid arthritis patients. [europepmc]
• Enhanced activity of NLRP3 inflammasome in peripheral blood cells of patients with active rheumatoid arthritis. [europepmc]
• Affective disturbance in rheumatoid arthritis: psychological and disease-related pathways. [europepmc]
• An Epstein-Barr Virus MicroRNA Blocks Interleukin-1 (IL-1) Signaling by Targeting IL-1 Receptor 1. [europepmc]
• IL1 genes polymorphism and the risk of renal cell carcinoma in Chinese Han population. [europepmc]
• Neuroimmune Crosstalk in Rheumatoid Arthritis. [europepmc]
• Impact of Biologic Drugs on Comorbidity Outcomes in Rheumatoid Arthritis: A Systematic Review. [europepmc]